Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$0.92 - $1.48 $3,001 - $4,827
-3,262 Reduced 81.86%
723 $0
Q1 2023

May 12, 2023

BUY
$1.43 - $2.0 $5,698 - $7,970
3,985 New
3,985 $5,000
Q3 2022

Nov 10, 2022

BUY
$2.97 - $23.6 $8,615 - $68,463
2,901 Added 695.68%
3,318 $9,000
Q2 2022

Aug 10, 2022

BUY
$2.81 - $5.5 $525 - $1,028
187 Added 81.3%
417 $1,000
Q1 2022

May 16, 2022

SELL
$3.42 - $6.37 $745 - $1,388
-218 Reduced 48.66%
230 $1,000
Q4 2021

Feb 14, 2022

SELL
$5.02 - $9.82 $3,177 - $6,216
-633 Reduced 58.56%
448 $2,000
Q3 2021

Nov 15, 2021

SELL
$3.23 - $24.73 $22,180 - $169,820
-6,867 Reduced 86.4%
1,081 $11,000
Q2 2021

Aug 13, 2021

BUY
$2.72 - $3.8 $19,581 - $27,356
7,199 Added 961.15%
7,948 $27,000
Q1 2021

May 12, 2021

SELL
$3.01 - $5.35 $5,237 - $9,309
-1,740 Reduced 69.91%
749 $3,000
Q4 2020

Feb 11, 2021

SELL
$1.5 - $3.64 $4,930 - $11,964
-3,287 Reduced 56.91%
2,489 $8,000
Q3 2020

Nov 12, 2020

BUY
$1.48 - $2.26 $8,548 - $13,053
5,776 New
5,776 $10,000
Q1 2020

May 01, 2020

SELL
$0.86 - $4.75 $1,510 - $8,341
-1,756 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$2.7 - $5.19 $4,741 - $9,113
1,756 New
1,756 $8,000

Others Institutions Holding NURO

# of Institutions
1
Shares Held
320
Call Options Held
0
Put Options Held
0

About NeuroMetrix, Inc.


  • Ticker NURO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 7,757,230
  • Market Cap $30.3M
  • Description
  • NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to e...
More about NURO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.